Synthesis of some 2-Pyridones by Application of L-L Phase Transfer Catalysis Method

Abstract:

Phase transfer catalysis P.T.C is one of the most widely used techniques in the preparation of a wide range of compounds not only in organic chemistry but also a broadly useful in several other areas of chemistry. There have been extensive studies that have been used to synthesize many compounds that are biologically important with highly efficient and the percentage of the product and purity are high with perfect time. In this study, a number of chalcones were prepared and reacted with phenoxy acetamide, 4-methyl phenoxy acetamide and phenyl mercapto acetamide for the preparation of 2–pyridones compounds under phase transfer catalysis conditions. The reaction mechanism and the structure of the resulting compounds were determined using physical analysis methods IR and ¹H-NMR. ¹³C-NMR was also measured for some compounds.

• Periodical: Materials Science Forum (Volume 1002)
• Pages: 448-456
• DOI: https://doi.org/10.4028/www.scientific.net/MSF.1002.448
• Online since: July 2020
• Authors: Asaad Mohammed Mustafa*, Mohammed Salim Hussein, Alarqam Zyaad Tareq
• Keywords: 2-Pyridones, Chalcones, Phase Transfer Catalysis P.T.C

References

[1] D. Albanese, Liquid–liquid phase transfer catalysis: basic principles and synthetic applications, Cata. Rev.: Sci. and Eng. 45:3-4 (2003) 369-395.

DOI: 10.1081/cr-120025538

[2] G. Gokel, W. Weber, Phase transfer catalysis. Part I: General principles, J. Chem. Edu. 55 (1978) 352.

[3] A. J. Burke, , C. S. Marques, N. J. Turner, G. J. Hermann, Active Pharmaceutical Ingredients in Synthesis: Catalytic Processes in Research and Development'', first ed., Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, (2018).

DOI: 10.1002/9783527807253

[4] Z. Siddiqui, S. Praveen, T. Musthafa, A. Ahmad, A. Khan, Thermal solvent-free synthesis of chromonyl chalcones, pyrazolines and their in vitro antibacterial, antifungal activities, J. Enzy. Inhib. Med. Chem. 27, (2012) 84-91.

DOI: 10.3109/14756366.2011.577035

[5] Z. Nowakowska, A review of anti-infective and anti-inflammatory chalcones, Eur. J. Med. Chem. 42 (2007) 125-137.

DOI: 10.1016/j.ejmech.2006.09.019

[6] Y. Lin, Y. Zhou, M. Flavin, L. Zhou, W. Nie, F. Chen, Chalcones and flavonoids as anti-tuberculosis agents, Bioorg. Med. Chem. 10 (2002) 2795-2802.

DOI: 10.1016/s0968-0896(02)00094-9

[7] R. Gacche, N. Dhole, S. Kamble, B. Bandgar, In-vitro evaluation of selected chalcones for antioxidant activity, J. Enzyme Inhib. Med. Chem. 23 (2008) 28-31.

DOI: 10.1080/14756360701306370

[8] M. Bonesi, M. Loizzo, G. Statti, S. Michel, F. Tillequin, F. Menichini, The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives, Bioorg. Med. Chem. Lett. 20 (2010) 1990-1993.

DOI: 10.1016/j.bmcl.2010.01.113

[9] N. Gorobets, B. Yousefi, F. Belaj, C. Kappe, Rapid microwave-assisted solution phase synthesis of substituted 2-pyridone libraries, Tetrahedron. 60 (2004) 8633––8644.

DOI: 10.1016/j.tet.2004.05.100

[10] A. Fassihi, D. Abedi, L. Saghaie, R. Sabet, H. Fazeli, G. Bostaki, Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives, Eur. J. Med. Chem. 44 (2009) 2145–2157.

DOI: 10.1016/j.ejmech.2008.10.022

[11] R. Parreira, O. Abrahão, S. Galembeck, Conformational preferences of non-nucleoside HIV-1 reverse transcriptase inhibitors, Tetrahedron. 57 (2001) 3243–3253.

DOI: 10.1016/s0040-4020(01)00193-4

[12] P. Dragovich, T. Prins, R. Zhou, E. Brown, F. Maldonado, S. Fuhrman, Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3c protease inhibitors, 6. structure−actvity studies of orally bioavailable, 2-pyridone-containing peptidomimetics, J. Med. Chem. 45 (2002) 1607–1623.

DOI: 10.1021/jm010469k

[13] Q. Li, L. Mitscher, L. Shen, The 2-pyridone antibacterial agents: bacterial topoisomerase inhibitors, Med. Res. Rev. 20 (2000) 231–293.

DOI: 10.1002/1098-1128(200007)20:4<231::aid-med1>3.0.co;2-n

[14] Y. Fujita, H. Oguri, H. Oikawa, Biosynthetic studies on the antibiotics PF1140: a novel pathway for a 2-pyridone framework, Tetrah. Lett. 46 (2005) 5885–5888.

DOI: 10.1016/j.tetlet.2005.06.115

[15] G. Semple, B. Andersson, V. Chhajlani, J. Georgsson, M. Johansson and Å. Rosenquist, Synthesis and biological activity of kappa opioid receptor agonists.part 2: preparation of 3-aryl-2-pyridone analogues generated by solution- and solid-phase parallel synthesis methods, Bioorg. Med. Chem. Lett. 13 (2003) 1141–1145.

DOI: 10.1016/s0960-894x(03)00033-7

[16] J. Parlow, R. Kurumbail, R. Stegeman, A. Stevens, W. Stallings, M. South, Design, Synthesis, and Crystal Structure of Selective 2-Pyridone Tissue Factor VIIa Inhibitors, J. Med. Chem. 46 (2003) 4696–4701.

DOI: 10.1021/jm0301686

[17] J. Parlow, M. South, Synthesis of 2-pyridones as tissue factor VIIa inhibitors, Tetrahedron. 59 (2003) 7695–7701.

DOI: 10.1016/s0040-4020(03)01239-0

[18] L. Hasvold, W. Wang, S. Gwaltney, T. Rockway, L. Nelson, R. Mantei, Pyridone containing farnesyl transferase inhibitors: synthesis and biological evaluation, Bioorg. Med. Chem. Lett. 13 (2003) 4001–4005.

DOI: 10.1016/j.bmcl.2003.08.058

[19] D. Mijin, G. Ušćumlić, N. Valentić and A. Marinković, Sinteza arilazo piridonskih boja, Hem. Ind. 65 (2011) 517–532.

[20] V. Litvinov, S. Krivokolysko, V. Dyachenko, Synthesis and properties of 3-cyanopyridine-2(1H)-chalcogenones: Review, Chem. Heterocyclic Comp. 35 (1999) 509–540.

DOI: 10.1007/bf02324634

[21] N. Pemberton, E. Chorell, F. Almqvist, Microwave-assisted synthesis and functionalization of 2-pyridones,2-quinolones and other ring-fused 2-pyridones, Top. Heter. Chem. 1 (2006) 1–30.

DOI: 10.1007/7081_006

[22] Z. Ismail, Reactivity of 1,3-diarylpropenones towards some nucleophilic reagents and screening of the biological activity of the products, J. of Amer. Sci. 9(7) (2013) 465-475.

[23] M. Kachroo, R. Panda, Y. Yadav, Synthesis and biological activities of some new pyrimidine derivatives from chalcones, Der Pharm. Chem. 6(2) (2014) 352-359.

[24] O. Mazimba, Antimicrobial activities of heterocycles derived from thienylchalcones, J. of King Saud Univ.–Sci. 27 (2015) 42–48.

DOI: 10.1016/j.jksus.2014.06.003

[25] D. Patel, DR. D. J. SEN, Synthesis and biological screening of some pyridazine derivatives, IJPRBS. 3(2) (2014) 760-769.

[26] E.Krein, Z.Aizenshat, Studies of heterocyclic compound, J. Org. Chem. 58 (1993) 6103 – 6108.

[27] N. AL-Rayyes, F. AL-Hajjar, Heterocycles. Part V. Reaction of α,β-unsaturated carbonyl compounds with arylacetamides. A synthesis of 2‐pyridone derivatives, J. Heter. Chem. 21, (1984) 1473.

DOI: 10.1002/jhet.5570210549

[28] M. Shandala, A. AL-Khashab, M.Afzal, S.S. Ahmed, Reactions of ethyl cinnamates with arylacetamides, J. Heter. Chem. 17 (1980) 1605.

DOI: 10.1002/jhet.5570170752